Clinical Trials Browser

Phase 3 × siltuximab × Plasma cell × Clear all

NCT01266811 2013-01-28

A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Phase 3 Withdrawn

Multiple Myeloma, Recurrence